Diabetes Prevention and Control in the Workplace: A Pilot Study
Recruitment status was Active, not recruiting
This worksite program for Onondaga County employees is a pilot research study aimed at decreasing the risk of developing diabetes (or improving metabolic control for adults with diabetes). The main goal is to improve the nutrition and physical habits of the participants, and promote weight loss in those who are overweight. The investigators will also examine factors that predict participation in the program and influence a participant's outcome/success in the program.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Diabetes Prevention and Control in the Workplace: A Pilot Study|
- Body weight [ Time Frame: Baseline, 3, 6, 12 months ] [ Designated as safety issue: No ]
- Fasting glucose level [ Time Frame: Baseline, 3, 6, 12 months ] [ Designated as safety issue: No ]
- Fasting lipid profile [ Time Frame: Baseline, 3, 6, 12 months ] [ Designated as safety issue: No ]
- hemoglobin A1c [ Time Frame: baseline, 3,6, 12 months ] [ Designated as safety issue: No ]
- waist circumference [ Time Frame: baseline, 3, 6, 12 months ] [ Designated as safety issue: No ]
- questionnaires [ Time Frame: baseline, 3, 6, 12 months ] [ Designated as safety issue: No ]
|Study Start Date:||July 2008|
|Estimated Primary Completion Date:||February 2010 (Final data collection date for primary outcome measure)|
Experimental: A, 1
A 3 month program (12 one hour weekly sessions) that targets healthy diet, physical activity and stress reduction, and then a monthly maintenance program for up to 2 years.
Behavioral: Diabetes Prevention and Control
The program will be delivered over 3 months in 12 one hour weekly mid-day sessions at the worksite. The curriculum has been adapted from the Diabetes Prevention Program, the National Diabetes Education Program and Conversation maps from Healthy Interactions Inc. Topics relate to healthy eating, physical activity, coping with disease and depression, and cardiovascular disease prevention. Additional topics may be included per feedback and need of the participants. After completion of the 3 month program, there will be monthly meetings.
No Intervention: A, 2
This is a "wait control" group, This group will begin the program (described in A,1) after 3 months.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00739336
|United States, New York|
|SUNY Upstate Medical University|
|Syracuse, New York, United States, 13210|
|Principal Investigator:||Ruth S Weinstock, MD, PhD||State University of New York - Upstate Medical University|